Italy· 039596022
RHESONATIV*1 fiala IM 2 ml 625 UI/ml
A medicinal product containing immunoglobulina umana anti-d, registered in Italy by OCTAPHARMA ITALY SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Immunoglobulina umana anti-D
- Manufacturer
- OCTAPHARMA ITALY SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic039596022RHESONATIV*1 fiala IM 2 ml 625 UI/mlEUR 70.97
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Immunoglobulina umana anti-d in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAnti-D (RHO) immunoglobulin 1,250units/1ml solution for injection pre-filled syringesBaxter Healthcare Ltd
- FinlandRhesonativOctapharma Ab
- United StatesHYPERRHOGRIFOLS USA, LLC
- NetherlandsRhesonativ 625 IE/ml, oplossing voor injectieOctapharma GmbH
- PolandGamma anty-D 150Synthaverse S.A.
- BelgiumImmunorho 300 µg/2 mlKedrion
- SwedenRhesonativ 625 IE/ml Injektionsvätska, lösningOctapharma AB
- CzechiaIGAMADInstituto Grifols, S.A., Barcelona
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Rhesonativ, Rhophylac
- Belgium · Immunorho, Rhophylac
- Bulgaria · Резонатив
- Cyprus · Rhesonativ, Rhophylac
- Czechia · Igamad, Rhesonativ
- Germany · Rhesonativ, Rhophylac
- Denmark · Rhesonativ, Rhophylac
- Estonia · Rhesonativ
- Spain · Igamad, Rhophylac
- Finland · Rhophylac
- France · Rhesonativ, Rhophylac
- United Kingdom (Northern Ireland) · D-Gam, Rhophylac
- Greece · Rhophylac
- Hungary · Rhesonativ, Rhophylac
- Ireland · Rhophylac
- Iceland · Rhesonativ, Rhophylac
- Lithuania · Rhesonativ
- Luxembourg · Rhesonativ, Rhophylac
- Latvia · Rhesonativ
- Malta · Rhesonativ, Rhophylac
- Netherlands · Rhesonativ, Rhophylac
- Norway · Rhesonativ, Rhophylac
- Poland · Gamma Anty-D, Rhesonativ
- Portugal · Rhesonativ, Rhophylac
- Romania · Rhesonativ, Rhophylac
- Sweden · Rhesonativ, Rhophylac
- Slovenia · Rhesonativ, Rhophylac
- Slovakia · Igamad, Rhesonativ
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c66185b3-3a97-4afb-a14a-24b59df4f9e0 GET /v1/drugs/c66185b3-3a97-4afb-a14a-24b59df4f9e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 70.97,
"source": "aifa",
"currency": "EUR",
"strength": "IMMUNOGLOBULINA UMANA ANTI-D 625UI 2ML 1 UNITA' USO PARENTERALE",
"substance": "Immunoglobulina umana anti-D",
"equivalence_group": "MZD",
"transparency_flag": null
}See everything about immunoglobulina umana anti-d.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.